z-logo
open-access-imgOpen Access
EV71 3C protease cleaves host anti-viral factor OAS3 and enhances virus replication
Author(s) -
Xiaolei Zhou,
Tian Li,
Jian Wang,
Baisong Zheng,
Wenyan Zhang
Publication year - 2022
Publication title -
virologica sinica
Language(s) - English
Resource type - Journals
eISSN - 1674-0769
pISSN - 1995-820X
DOI - 10.1016/j.virs.2022.04.013
Subject(s) - biology , ns2 3 protease , viral replication , protease , coxsackievirus , enterovirus 71 , virus , cleave , picornavirus , virology , gene , rna , enterovirus , genetics , enzyme , biochemistry
The global spread of enteroviruses (EVs) has become more frequent, severe and life-threatening. Intereron (IFN) I has been proved to control EVs by regulating IFN-stimulated genes (ISG) expression. 2'-5'-oligoadenylate synthetases 3 (OAS3) is an important ISG in the OAS/RNase L antiviral system. The relationship between OAS3 and EVs is still unclear. Here, we reveal that OAS3, superior to OAS1 and OAS2, significantly inhibited EV71 replication in vitro. However, EV71 utilized autologous 3C protease (3C pro ) to cleave intracellular OAS3 and enhance viral replication. Rupintrivir, a human rhinovirus 3C protease inhibitor, completely abolished the cleavage of EV71 3C pro on OAS3. And the proteolytically deficient mutants H40G, E71A, and C147G of EV71 3C pro also lost the ability of OAS3 cleavage. Mechanistically, the Q982-G983 motif in C-terminal of OAS3 was identified as a crucial 3C pro cutting site. Further investigation indicated that OAS3 inhibited not only EV71 but also Coxsackievirus B3 (CVB3), Coxsackievirus A16 (CA16), Enterovirus D68 (EVD68), and Coxsackievirus A6 (CA6) subtypes. Notably, unlike other four subtypes, CA16 3C pro could not cleave OAS3. Two key amino acids variation Ile36 and Val86 in CA16 3C pro might result in weak and delayed virus replication of CA16 because of failure of OAS and 3AB cleavage. Our works elucidate the broad anti-EVs function of OAS3, and illuminate a novel mechanism by which EV71 use 3C pro to escape the antiviral effect of OAS3. These findings can be an important entry point for developing novel therapeutic strategies for multiple EVs infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom